| pubmed-article:6366033 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6366033 | lifeskim:mentions | umls-concept:C0021083 | lld:lifeskim |
| pubmed-article:6366033 | lifeskim:mentions | umls-concept:C0002792 | lld:lifeskim |
| pubmed-article:6366033 | lifeskim:mentions | umls-concept:C0040871 | lld:lifeskim |
| pubmed-article:6366033 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:6366033 | pubmed:dateCreated | 1984-4-24 | lld:pubmed |
| pubmed-article:6366033 | pubmed:abstractText | A successful program of immunotherapy for Triatoma protracta-induced anaphylaxis was developed. This program included a new passive extract-antigen preparation standardized by RAST inhibition. This antigen facilitated the development of a reliable skin test protocol for in vivo diagnosis of Triatoma protracta allergy. Five patients with T. protracta-induced anaphylaxis underwent a rapidly increasing dosage schedule of immunotherapy. The IgE- and IgG-antibody responses during immunotherapy were followed with solid-phase RIA. Protection against anaphylaxis was confirmed in all patients with a "bite challenge" by T. protracta. This is the first report of completely successful T. protracta immunotherapy. | lld:pubmed |
| pubmed-article:6366033 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6366033 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6366033 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6366033 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6366033 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6366033 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:6366033 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6366033 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6366033 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:6366033 | pubmed:issn | 0091-6749 | lld:pubmed |
| pubmed-article:6366033 | pubmed:author | pubmed-author:SaxonAA | lld:pubmed |
| pubmed-article:6366033 | pubmed:author | pubmed-author:PopaCC | lld:pubmed |
| pubmed-article:6366033 | pubmed:author | pubmed-author:MarshallN ANA | lld:pubmed |
| pubmed-article:6366033 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6366033 | pubmed:volume | 73 | lld:pubmed |
| pubmed-article:6366033 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6366033 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6366033 | pubmed:pagination | 369-75 | lld:pubmed |
| pubmed-article:6366033 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:6366033 | pubmed:meshHeading | pubmed-meshheading:6366033-... | lld:pubmed |
| pubmed-article:6366033 | pubmed:meshHeading | pubmed-meshheading:6366033-... | lld:pubmed |
| pubmed-article:6366033 | pubmed:meshHeading | pubmed-meshheading:6366033-... | lld:pubmed |
| pubmed-article:6366033 | pubmed:meshHeading | pubmed-meshheading:6366033-... | lld:pubmed |
| pubmed-article:6366033 | pubmed:meshHeading | pubmed-meshheading:6366033-... | lld:pubmed |
| pubmed-article:6366033 | pubmed:meshHeading | pubmed-meshheading:6366033-... | lld:pubmed |
| pubmed-article:6366033 | pubmed:meshHeading | pubmed-meshheading:6366033-... | lld:pubmed |
| pubmed-article:6366033 | pubmed:meshHeading | pubmed-meshheading:6366033-... | lld:pubmed |
| pubmed-article:6366033 | pubmed:meshHeading | pubmed-meshheading:6366033-... | lld:pubmed |
| pubmed-article:6366033 | pubmed:meshHeading | pubmed-meshheading:6366033-... | lld:pubmed |
| pubmed-article:6366033 | pubmed:meshHeading | pubmed-meshheading:6366033-... | lld:pubmed |
| pubmed-article:6366033 | pubmed:meshHeading | pubmed-meshheading:6366033-... | lld:pubmed |
| pubmed-article:6366033 | pubmed:year | 1984 | lld:pubmed |
| pubmed-article:6366033 | pubmed:articleTitle | Successful immunotherapy for Triatoma protracta-induced anaphylaxis. | lld:pubmed |
| pubmed-article:6366033 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6366033 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:6366033 | pubmed:publicationType | Case Reports | lld:pubmed |
